Optical Coherence Tomography Market Size, Share, Growth - By Technology, By Type, By Application, By End Use - Global Forecast, 2025 - 2034

Optical Coherence Tomography Market Size

The global optical coherence tomography market was valued at USD 1.9 billion in 2024 and is projected to exhibit 12.8% CAGR from 2025-2034. Optical coherence tomography employs low-coherence light waves and is a non-invasive imaging technique that extracts high-resolution cross-sectioned images of biological tissues.
 

The increasing number in ophthalmic disease cases, including age-related macular degeneration (AMD), diabetic neuropathy, and glaucoma, is driving the demand for optical coherence tomography (OCT) diagnostics. For instance, the International Agency for the Prevention of Blindness (IAPB) states that approximately 5% of all blindness cases globally are caused by AMD. Further, as per 2022 study published by Cureus Journal of Medical Science, about 200 million individuals are expected to be affected by AMD by 2040 across the world, which is expected to increase to 300 million by 2050. Such ophthalmic conditions necessitate high-quality imaging for effective treatment planning, ongoing monitoring, and early detection, highlighting the crucial role of OCT as a critical tool for ophthalmology.
 

Furthermore, the rapidly increasing global aging population, especially in developed countries, has resulted in the growing burden for chronic eye-related conditions. As per the World Health Organization (WHO), for example, the number of individuals aged 60 and above will reach 1.4 billion by the year 2030. Hence, the growing population of elderly patients is likely to increase the need for efficient diagnostic tools like OCT, which would enhance its market value.
 

Furthermore, due to the significant investments in research and development of novel technologies which are designed to provide end users with precise diagnostic results, deeper tissue access, and rapid image capture, new and advanced therapies are being introduced. For instance, Abbott Laboratories published in the U.S. Food and Drug Administration (FDA) approval of its novel OCT imaging platform integrated with its innovative Ultreon software. The advanced software utilized artificial intelligence (AI) for advanced diagnostics. Advancements such as these provide significant market growth potential, supplementing the increasing demand for advanced ophthalmic diagnostic tools.
 

Optical Coherence Tomography Market Trends

• An increasing preference for handheld, compact, and portable OCT systems due to the increasing demand for point-of-care diagnostics and improved accessibility in rural areas, mobile clinics, homecare, and outpatient settings is prompting manufacturers to develop and introduce such compact OCT devices.
   
• The development of technologies such as visible light OCT (Vis-OCT), which use visible light for OCT illumination rather than near-infrared light to obtain high-resolution images with better resolution of retinal features, has spurred significant research and development activities in the market.
   
• Several recent technological advancements in OCTs, such as swept-source OCT and depth imaging OCT, have improved comprehensive investigation of the choroid. As well as improvement of new OCT angiography (OCTA) technology in producing high-definition retinal imagery.
   
• Additionally, the use of AI and machine learning algorithms on OCT platforms is revolutionizing diagnostic efficiency and accuracy. The technologies assist in predictive analytics, automated image segmentation, and disease detection.
   
• Moreover, the market is also witnessing a massive trend towards swept-source OCT (SS-OCT) machines as it offers greater resolution, speed, and image clarity than traditional OCT machines.
   

Trump Administration Tariffs

• The tariffs imposed by the Trump administration are expected to cause significant disruptions in the global supply chain, majorly affecting the U.S.-based OTC device manufacturers that are dependent on outsourced components from providers in China and Europe.
   
• Additionally, this can result in delayed procurement of critical components such as optical beam splitter, optical fibres, transverse scanners, detectors, and lasers, resulting in possible bottlenecks and high overall manufacturing costs.
   
• Various healthcare providers may have to pay higher prices for OCT systems because of the increasing manufacturing costs. This can impact small-scale healthcare providers that lack the financial capacity to allocate such significant amounts.
   
• Companies can adapt to the supply chain disruptions and cost hikes through cost optimization and supplier diversification. Moreover, manufacturers in China are expected to strengthen their presence in the Asia and Africa regions having significant untapped potential for OCT devices.
   

Optical Coherence Tomography Market Analysis

Based on technology, the market is segmented into time domain OCT, spectral domain OCT, and swept-source OCT. The spectral domain OCT segment dominated the market with the largest revenue share of 61.9% in 2024.
 

• The growing cases of age-related macular degeneration, diabetic retinopathy, glaucoma, and other eye diseases that affect the retina are progressively triggering ophthalmological demand for spectral domain OCT equipment. For instance, in the year 2020 an estimated 80 million individuals across the globe had glaucoma, according to the Glaucoma Research Foundation.
   
• SD-OCT devices are applied widely not just for retinal imaging but also for the examination of the optic nerve, anterior segment, and corneal disease. Their capacity to accommodate such an enormous array of clinical applications from glaucoma staging to post-operative examination adds value in comprehensive eye care.
   
• Furthermore, continued innovation in image analysis software such as AI-driven retinal layer segmentation, computerized disease detection, and longitudinal change analysis is improving the clinical value of SD-OCT, thereby facilitating the segment growth.
   

Based on type, the optical coherence tomography market is segmented into tabletop OCT devices, catheter-based OCT devices, handheld OCT devices, and doppler OCT devices. The tabletop OCT devices segment dominated the market with a share of 46.1% in 2024.
 

• Tabletop OCT devices are the preferred option for ophthalmic disease diagnostics due to their compatibility with several scanning modalities, high precision imaging, and stability. These machines are largely used in specialty clinics, ophthalmic centers, and hospitals for anterior segment evaluation, glaucoma assessment and retinal imaging.
   
• Moreover, contemporary tabletop systems are usually followed by sophisticated technologies like scanning laser ophthalmoscopy, fluorescein angiography, and fundus camera, leading to an integrated workstation.
   
• For example, in September 2024, Topcon released the U.S. FDA clearance of its OCTA OCT color fundus camera system. It was the very first and sole of its kind fundus camera in the U.S.
   

Based on application, the optical coherence tomography market is segmented into ophthalmology, cardiology, dermatology, oncology, and other applications. The ophthalmology segment dominated the market with a share of 69.2% in 2024.
 

• The growing incidence of age-related macular degeneration, diabetic retinopathy, glaucoma, and other retinal diseases drives the demand for OCT systems in ophthalmology. According to the World Health Organization (WHO), approximately 2.2 billion people globally had vision impairment in 2022.
   
• Additionally, according to BMC Ophthalmology, in the year 2024 about 30% were influenced by diabetic retinopathy. These conditions necessitate repeated and accurate imaging of retinal layers and optic nerve structures, which are reconstructed by OCT devices using non-invasive, high-resolution imaging.
   
• Modern ophthalmic OCT scanners apply enhanced depth imaging, swept-source imaging, and OCTA to image structures more posterior and the retinal vascular bed without the need for staining, driving the need for devices.

Based on end use, the optical coherence tomography market is segmented into hospitals, diagnostic imaging centers, ambulatory surgical centers, and other end users. The hospitals segment dominated the market with the largest revenue of USD 1.1 billion in 2024.
 

• Hospitals, especially tertiary and quaternary care hospitals, need sophisticated imaging technology to facilitate advanced diagnostics and specialty care. OCT systems offer high-resolution visualization of ocular and cardiovascular tissues, facilitating early detection of disease and planning for treatment.
   
• Hospitals developing specialty services in ophthalmology, cardiology, and oncology employ OCT for high-resolution, non-invasive imaging to enhance clinical outcomes, minimize diagnostic uncertainty, and facilitate multidisciplinary care.
   
• OCT systems are compatible with hospital networks, including electronic medical records (EMRs) and picture archiving and communication systems (PACS). This enables data sharing, facilitates telemedicine programs, and improves patient monitoring for chronic disease management.
   
• Hospitals select OCT solutions with data automation and connectivity capabilities to reduce administrative work, improve accuracy, and implement clinical decision support tools for patient management.

North America: The U.S. optical coherence tomography market is projected to grow significantly from USD 786.4 million in 2024 to USD 2.6 billion by 2034.
 

• Large share of U.S. population has aged (approx. 17% of population in 2023 were above 65 years of age as per the World Bank Group), and with it, age-related eye disorders such as macular degeneration, diabetic retinopathy, and glaucoma have increased. OCT is an important part of early diagnosis and monitoring of these conditions. Over 20% of the population will be 65 or older by the year 2030, as estimated by the U.S. Census Bureau.
   
• Moreover, the National Eye Institute approximates that 3 million U.S. citizens had glaucoma in 2024 and is estimated to increase up to 4.2 million by the year 2030. Such demographic changes and patterns of disease incidence suggest a strong demand for ophthalmic diagnostic technologies.
   
• Further, Medicare (CMS) and private payers offer wide reimbursement coverage for OCT procedures in the U.S. market. Reimbursement policies cover different applications of OCT, such as retina scans, optic nerve analysis, and OCT angiography.
   
• Such financial coverage saves costs for patients and providers, and encourages broader use in eye care practices, especially outpatient. The reimbursement structure set up continues to encourage the spread of OCT technology used in clinical practice.
   

Europe: The optical coherence tomography market in UK is expected to experience significant and promising growth from 2025 to 2034.
 

• The National Health Service (NHS) of the UK has increased the availability of OCT scans through initiatives such as the NHS Long Term Plan, especially in community optometry environments.
   
• Additionally, the integration of OCT imaging across diagnostic practices by primary eye care practitioners is increasing the demand for OCT devices in the UK. This is also helping in relieving hospital ophthalmology departments from the workload and further improving early detection of sight-threatening disorders in the country.
   
• Moreover, diabetic retinopathy and AMD remain primary causes of vision loss in the UK, especially among people aged over 60 years. For instance, according to the National Institute for Health and Care Excellence, each year approximately 39,800 individuals in the UK develop neovascular AMD. This high volume of cases significantly drives the demand for advanced diagnostic tools in the region.
   

Asia Pacific: Japan optical coherence tomography market is anticipated to witness lucrative growth between 2025 – 2034.
 

• Ageing of the Japanese population has brought an upsurge in the prevalence rates of age-related disorders like AMD, DME, and glaucoma that emphasize the growing need for sophisticated diagnostic equipment. For instance, Statista indicated that in 2023, individuals aged 65 years and older in Japan comprised approximately 29.6 percent of the total Japanese population.
   
• Moreover, the market for Japan's ophthalmic imaging has presence of some of the leading companies like Canon, NIDEK, and Topcon that are global pioneers in OCT innovation technology. Their presence in the region ensures real-time access to products, efficient after-sales services, and ongoing innovation depending on local clinical demands.
   
• Such production capacity supports the growth of Japan's domestic market and makes Japan a significant exporter in the global OCT market, further solidifying its status as an ophthalmic imaging technology center.
   
• Furthermore, the Japanese health system focuses on the timely detection and management of chronic disease through national health programs (such as Ningen Dock) as well as routine screening programs. OCT scans receive greater coverage by the public health insurance, especially to monitor diabetes and glaucoma.
   
• Encouraging such a favorable reimbursement climate drives healthcare facilities to adopt OCT systems, increasing the technology's prestige in preventive care in the country and supporting Japan in developing its advanced eye care facilities.
   

Middle East and Africa: The Saudi Arabia optical coherence tomography market is expected to experience significant and promising growth from 2025 to 2034.
 

• Saudi Arabia has the highest prevalence of diabetes in the world, and this is attributed to several factors including unhealthy lifestyle, diet, and physical inactivity. For example, as per the International Diabetes Federation, diabetes prevalence in Saudi Arabia in 2021 was 17.7%. Diabetic retinopathy, being a severe complication, necessitates repeated high-resolution medical imaging to track retinal status and avoid vision loss.
   
• OCT devices are increasingly being installed in government and private clinics to detect early retinal injury and address the increasing cost of diabetes eye complications in the country, significantly increasing early detection rates.
   
• Saudi Arabia's Vision 2030 initiative is centered on healthcare modernization through digitalization, early diagnosis, and improved service delivery. OCT systems, particularly when integrated with AI and telemedicine platforms, align with these goals of modernization.
   
• Their application is increasing in ophthalmology units and new specialty centers in the public-private partnership scheme, thereby facilitating their adoption across the country.
   

Optical Coherence Tomography Market Share

The optical coherence tomography industry is segmented and controlled by a dynamic mix of international and domestic players providing innovative solutions to meet the growing demand for advanced diagnostic tools with enhance accuracy and faster diagnosis rates. Companies such as Carl Zeiss Meditec, Topcon, Abbott Laboratories, Heidelberg Engineering, and Canon Medical Systems are some of the dominant competitors in the market accounting for a combined market share of approximately 60%. Competition in this area arises from continuous technological developments and the ability to offer customized solutions for various diagnostic applications. In developing nations, due to the priority given to cost, multinational companies are squeezed to offer optical coherence tomography that are both affordable and of quality. Domestic manufacturers take advantage of this demand by providing cost effective alternatives, which make multinationals alter their price strategy while maintaining the safety, ruggedness, and regulatory acceptability of the products.
 

Optical Coherence Tomography Market Companies

Some of the eminent market participants operating in the optical coherence tomography industry include:

• Abbott Laboratories
• Agfa-Gevaert
• Canon Medical Systems
• Carl Zeiss Meditec
• Danaher
• Heidelberg Engineering
• Michelson Diagnostics
• NIDEK
• Novacam Technologies
• OPTOPOL Technology
• Optos
• Santec
• Thorlabs
• Topcon
• ZD Medical
   
• Carl Zeiss is a leading player with its Cirrus HD-OCT and AngioPlex systems, which offer high-resolution imaging and structural-angiographic functionality for retinal diagnostics. Zeiss's OCT platforms are able to integrate with surgical platforms such as cataract and refractive lasers, making them more beneficial in ophthalmic clinics and hospitals. Carl Zeiss's systems enable automated tracking of disease progression for glaucoma and macular degeneration to support clinical decisions. Its international service network ensures maximum equipment availability through proper maintenance and upgrading.
   
• Topcon's 3D OCT-1 Maestro and Triton platforms offer ultra-widefield imaging of anterior and posterior ocular segments. The company's swept-source OCT technology delivers rapid, clean scanning that is useful in high-volume clinical settings. Topcon couples several imaging modalities by pairing OCT with fundus photography and fluorescein angiography in the same devices.
   
• Abbott Laboratories' ILUMIEN OPTIS system is one of the leading intravascular OCT technology applied for high-resolution coronary artery imaging in percutaneous coronary intervention (PCI) cases. The stent optimization capabilities of the system enable cardiologists to assess vessel morphology, plaque, and stent position.
   

Optical Coherence Tomography Industry News

• In June 2024, NIDEK CO., LTD. announced the launch of its RS-1 Glauvas Optical Coherence Tomography system. The RS-1 Glauvas had a scan speed of up to 250 kHz, high-quality wide and deep area imaging, easy-to-use operability, and deep learning–based analytics. This launch reinforced NIDEK's product line in sophisticated ocular diagnostics and bolstered its market position in the international OCT market.
   
• In May 2024, ZEISS Medical Technology announced the launch of CIRRUS 6000 coupled with a highly effective, data-driven workflow for ophthalmologists, backed by the largest OCT reference database in the U.S. and recently upgraded cybersecurity features. This development solidified ZEISS's leadership in ophthalmic diagnostics and enabled its strategy to provide secure, data-driven imaging solutions to eye care professionals.
   
• In July 2024, Heidelberg Engineering, a worldwide leader in ophthalmic imaging and healthcare data solutions, announced FDA clearance of the SPECTRALIS OCTA Module with SHIFT technology that decreased image acquisition time by 50%. The clearance provided expanded U.S. offerings for the company and grew its capacity to provide quicker, more efficient imaging solutions to eye care practices.
   
• In August 2021, Abbott announced U.S. FDA approval for its next-generation optical coherence tomography (OCT) imaging system, powered by the company's innovative Ultreon Software. The high-performance imaging software combined OCT with artificial intelligence (AI) to give physicians a deeper, comprehensive view of coronary blood flow and blockages, and facilitate more astute decision-making and treatment planning. The approval consolidated the leadership of Abbott in intravascular imaging and demonstrated its commitment towards integration of AI to facilitate enhanced cardiovascular treatment.
   

The optical coherence tomography market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

By Technology

• Spectral domain OCT
• Swept-source OCT
• Time domain OCT

By Type

• Tabletop OCT devices
• Catheter based OCT devices
• Handheld OCT devices
• Doppler OCT devices

By Application

• Ophthalmology
• Cardiology
• Dermatology
• Oncology
• Other applications

By End Use

• Hospitals
• Diagnostic imaging centers
• Ambulatory surgical centers
• Other end use

The above information is provided for the following regions and countries:

• North America 
  • U.S.
  • Canada 
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Netherlands 
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea 
• Latin America
  • Brazil
  • Mexico
  • Argentina 
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE